Back to results
US 9,169,504 B2Granted
Method for producing pyripyropene
AssigneeMeiji Seika Pharma Co., Ltd.
InventorsHiroyuki Anzai, Kentaro Yamamoto, Kazuhiko Oyama, Mariko Tsuchida, Kimihiko Goto, Masaaki Mitomi
Life of this patent
Estimating the term…
Abstract
There is provided a method for culturing a microorganism in which a particular polynucleotide or a recombinant vector comprising it/them is introduced with an intermediate compound necessary for biosynthesis of pyripyropene A. The method of the present invention allows for the production of pyripyropene.
Claims5
A method for producing pyripyropene A, comprising:
- culturing a microorganism in the presence of pyripyropene E to produce pyripyropene A and isolating the pyripyropene A, wherein said microorganism is transformed with at least one heterologous polynucleotide in (I) to (Ill) below or a recombinant vector comprising said heterologous polynucleotide:
- (I) a heterologous polynucleotide having at least one nucleotide sequence selected from the nucleotide sequences in (a) to (d) below:
- (a) the nucleotide sequence of SEQ ID NO:
- 266,
- (b) a nucleotide sequence which is capable of hybridizing with every nucleotide in the full length complementary sequence in SEQ ID NO:
- 266 under stringent conditions wherein said stringent conditions comprise washing with 2× saline-sodium citrate (SSC) buffer and 0.5% sodium dodecyl sulfate (SDS) at 60° C. for 20 minutes, and then washing 0.2×SSC and 0.1% SDS at 60° C. for 15 minutes,
- (c) the nucleotide sequence of SEQ ID NO:
- 266 in which one to ten nucleotides are deleted, substituted, inserted or added, and
- (d) a nucleotide sequence which has at least 90% identity the nucleotide sequence of SEQ ID NO:
- 266;
- wherein positions of the nucleotide sequence corresponding to positions 3342 to 5158 in SEQ ID NO:
- 266 encode a protein having CoA ligase activity, positions of the nucleotide sequence corresponding to positions 5382 to 12777 in SEQ ID NO:
- 266 encode a protein having LovB-like polyketide synthase activity, positions of the nucleotide sequence corresponding to positions 13266 to 15144 in SEQ ID NO:
- 266 encode a protein having Cytochrome P450 monooxygenase-1 activity, positions of the nucleotide sequence corresponding to positions 16220 to 18018 in SEQ ID NO:
- 266 encode a protein having Cytochrome P450 monooxygenase-2 activity, positions of the nucleotide sequence corresponding to positions 18506 to 19296 in SEQ ID NO:
- 266 encode a protein having Cyclase activity, positions of the nucleotide sequence corresponding to positions 19779 to 21389 in SEQ ID NO:
- 266 encode a protein having FAD-dependent monooxygenase activity, positions of the nucleotide sequence corresponding to positions 21793 to 22877 in SEQ ID NO:
- 266 encode a protein having UbiA-like prenyltransferase activity, positions of the nucleotide sequence corresponding to positions 23205 to 24773 in SEQ ID NO:
- 266 encode a protein having Acetyltransferase activity, and positions of the nucleotide sequence corresponding to positions 25824 to 27178 in SEQ ID NO:
- 266 encode a protein having Acetyltransferase-2 activity;
- (II) a heterologous polynucleotide having a nucleotide sequence encoding the amino acid sequences of SEQ ID NOs:
- 267-275 or an amino acid sequence having one to ten substituted, deleted, added, or inserted residues in the amino acid sequences of SEQ ID NOs:
- 267-275 and having the same enzymatic activity as the amino acid sequences set forth in SEQ ID NOs:
- 267-275, respectively,
- wherein SEQ ID NO:
- 267 is a protein having CoA ligase activity, SEQ ID NO:
- 268 is a protein having LovB-like polyketide synthase activity, SEQ ID NO:
- 269 is a protein having Cytochrome P450 monooxygenase-1 activity, SEQ ID NO:
- 270 is a protein having Cytochrome P450 monooxygenase-2 activity, SEQ ID NO:
- 271 is a protein having cyclase activity, SEQ ID NO:
- 272 is a protein having FAD-dependent monooxygenase activity, SEQ ID NO:
- 273 is a protein having UbiA-like prenyltransferase activity, SEQ ID NO:
- 274 is a protein having Acetyltransferase activity, and SEQ ID NO:
- 275 is a protein having Acetyltransferase-2 activity;
- (III) a heterologous polynucleotide having at least one nucleotide sequence selected from the group consisting of the nucleotide sequences set forth in (1) to (4) below:
- (1) the nucleotide sequences set forth in (a) to (i) below:
- (a) a nucleotide sequence comprising positions 3342 to 5158 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (b) a nucleotide sequence comprising positions 5382 to 12777 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (c) a nucleotide sequence comprising positions 13266 to 15144 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (d) a nucleotide sequence comprising positions 16220 to 18018 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (e) a nucleotide sequence comprising positions 18506 to 19296 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (f) a nucleotide sequence comprising positions 19779 to 21389 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (g) a nucleotide sequence comprising positions 21793 to 22877 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (h) a nucleotide sequence comprising positions 23205 to 24773 of the nucleotide sequence set forth in SEQ ID NO:
- 266, and
- (i) a nucleotide sequence comprising positions 25824 to 27178 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (2) a nucleotide sequence which hybridizes with every nucleotide in the full length complementary sequence in (1) under stringent conditions wherein said stringent conditions comprise washing with 2× saline-sodium citrate (SSC) buffer and 0.5% sodium dodecyl sulfate (SDS) at 60° C. for 20 minutes, and then washing with 0.2×SSC and 0.1% SDS at 60° C. for 15 minutes;
- (3) the nucleotide sequence in (1) in which one to ten nucleotides are deleted, substituted, inserted or added, and
- (4) a nucleotide sequence with at least 90% sequence identity to the nucleotide sequence in (1),
- wherein positions of the nucleotide sequences of (1) to (4) corresponding to positions 3342 to 5158 in SEQ ID NO:
- 266 encode a protein having CoA ligase activity, positions of the nucleotide sequence corresponding to positions 5382 to 12777 in SEQ ID NO:
- 266 encode a protein having LovB-like polyketide synthase activity, positions of the nucleotide sequence corresponding to positions 13266 to 15144 in SEQ ID NO:
- 266 encode a protein having Cytochrome P450 monooxygenase-1 activity, positions of the nucleotide sequence corresponding to positions 16220 to 18018 in SEQ ID NO:
- 266 encode a protein having Cytochrome P450 monooxygenase-2 activity, positions of the nucleotide sequence corresponding to positions 18506 to 19296 in SEQ ID NO:
- 266 encode a protein having Cyclase activity, positions of the nucleotide sequence corresponding to positions 19779 to 21389 in SEQ ID NO:
- 266 encode a protein having FAD-dependent monooxygenase activity, positions of the nucleotide sequence corresponding to positions 21793 to 22877 in SEQ ID NO:
- 266 encode a protein having UbiA-like prenyltransferase activity, positions of the nucleotide sequence corresponding to positions 23205 to 24773 in SEQ ID NO:
- 266 encode a protein having Acetyltransferase activity, and positions of the nucleotide sequence corresponding to positions 25824 to 27178 in SEQ ID NO:
- 266 encode a protein having Acetyltransferase-2 activity.
64 more elements
A method for producing pyripyropene A, comprising:
- culturing a microorganism in the presence of pyripyropene E to produce pyripyropene A and isolating the pyripyropene A, wherein said microorganism is transformed with at least one heterologous polynucleotide in (I) to (II) below or a recombinant vector comprising said heterologous polynucleotide:
- (I) a heterologous polynucleotide having a nucleotide sequence encoding polypeptides comprising the amino acid sequences of SEQ ID NOs:
- 269, 270, and 275 or an amino acid sequence having one to ten substituted, deleted, added, or inserted residues in the amino acid sequences of SEQ ID NOs:
- 269, 270, and 275 and having the same enzymatic activity as the amino acid sequences set forth in SEQ ID NOs:
- 269, 270, and 275, respectively;
- wherein SEQ ID NO:
- 269 is a protein having Cytochrome P450 monooxygenase-1 activity, SEQ ID NO:
- 270 is a protein having Cytochrome P450 monooxygenase-2 activity, and SEQ ID NO:
- 275 is a protein having Acetyltransferase-2 activity;
- (II) a heterologous polynucleotide having a nucleotide sequence selected from the group consisting of the nucleotide sequences in (1) to (4) below:
- (1) the nucleotide sequences set forth in (a) to (c) below:
- (a) a nucleotide sequence comprising positions 13266 to 15144 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (b) a nucleotide sequence comprising positions 16220 to 18018 of the nucleotide sequence set forth in SEQ ID NO:
- 266, and
- (c) a nucleotide sequence comprising positions 25824 to 27178 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (2) a nucleotide sequence which is capable of hybridizing with every nucleotide in the full length complementary sequence in (1) under stringent conditions wherein said stringent conditions comprise washing with 2× saline-sodium citrate (SSC) buffer and 0.5% sodium dodecyl sulfate (SDS) at 60° C. for 20 minutes, and then washing with 0.2×SSC and 0.1% SDS at 60° C. for 15 minutes;
- (3) the nucleotide sequence in (1) in which one to ten nucleotides are deleted, substituted, inserted or added, and;
- (4) a nucleotide sequence comprising at least 90% sequence identity to the nucleotide sequence in (1),
- wherein positions of the nucleotide sequence corresponding to positions 13266 to 15144 in SEQ ID NO:
- 266 encode a protein having Cytochrome P450 monooxygenase-1 activity, positions of the nucleotide sequence corresponding to positions 16220 to 18018 in SEQ ID NO:
- 266 encode a protein having Cytochrome P450 monooxygenase-2 activity, and positions of the nucleotide sequence corresponding to positions 25824 to 27178 in SEQ ID NO:
- 266 encode a protein having Acetyltransferase-2 activity.
21 more elements
A method for producing pyripyropene A, comprising:
- culturing a microorganism in the presence of deacetyl pyripyropene E to produce pyripyropene A and isolating the pyripyropene A, wherein said microorganism is transformed with at least one heterologous polynucleotide in (I) and (II) below or a recombinant vector comprising said heterologous polynucleotide:
- (VI) a heterologous polynucleotide having a nucleotide sequence encoding the amino acid sequences of SEQ ID NOs:
- 269, 270, 274, and 275,
- wherein SEQ ID NO:
- 269 is a protein having Cytochrome P450 monooxygenase-1 activity, SEQ ID NO:
- 270 is a protein having Cytochrome P450 monooxygenase-2 activity, SEQ ID NO:
- 274 is a protein having Acetyltransferase activity, and SEQ ID NO:
- 275 is a protein having Acetyltransferase-2 activity;
- (VII) a heterologous polynucleotide having a nucleotide sequence selected from the group consisting of the nucleotide sequences in (1) to (4) below:
- (1) the nucleotide sequences set forth in (a) to (d) below:
- (a) a nucleotide sequence comprising positions 13266 to 15144 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (b) a nucleotide sequence comprising positions 16220 to 18018 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (c) a nucleotide sequence comprising positions 23205 to 24773 of the nucleotide sequence set forth in SEQ ID NO:
- 266, and
- (d) a nucleotide sequence comprising positions 25824 to 27178 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (2) a nucleotide sequence which hybridizes with every nucleotide in the full length complementary sequence in (1) under stringent conditions wherein said stringent conditions comprise washing with 2× saline-sodium citrate (SSC) buffer and 0.5% sodium dodecyl sulfate (SDS) at 60° C. for 20 minutes, and then washing with 0.2×SSC and 0.1% SDS at 60° C. for 15 minutes;
- (3) the nucleotide sequence in (1) in which one to ten nucleotides are deleted, substituted, inserted, or added, and;
- (4) a nucleotide sequence comprising at least 90% sequence identity to the nucleotide sequence in (1)
- wherein positions of the nucleotide sequence corresponding to positions 13266 to 15144 in SEQ ID NO:
- 266 encode a protein having Cytochrome P450 monooxygenase-1 activity, positions of the nucleotide sequence corresponding to positions 16220 to 18018 in SEQ ID NO:
- 266 encode a protein having Cytochrome P450 monooxygenase-2 activity, positions of the nucleotide sequence corresponding to positions 23205 to 24773 in SEQ ID NO:
- 266 encode a protein having Acetyltransferase activity, and positions of the nucleotide sequence corresponding to positions 25824 to 27178 in SEQ ID NO:
- 266 encode a protein having Acetyltransferase-2 activity.
23 more elements
A method for producing 4-hydroxy-6-(pyridine-3-yl)-3-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl)-2H-pyrane-2-one comprising:
- culturing a microorganism in the presence of 4-oxo-6-(3-pyridyl)-α-pyrone and isolating 4-hydroxy-6-(pyridine-3-yl)-3-((2E,6E),3,7,11-trimethyldodeca-2,6,10-trienyl)-2H-pyrane-2-one to produce 4-hydroxy-6-(pyridine-3-yl)-3-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl)-2H-pyrane-2-one and isolating the 4-hydroxy-6-(pyridine-3-yl)-3-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl)-2H-pyrane-2-one, wherein said microorganism is transformed with at least one heterologous polynucleotide in (I) and (II) below or a recombinant vector comprising said heterologous polynucleotide:
- (I) a heterologous polynucleotide having a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:
- 273 or the amino acid sequence of SEQ ID NO:
- 273 having one to ten substituted, deleted, added, or inserted residues and having the same enzymatic activity as the amino acid sequence of SEQ ID NO:
- 273,
- wherein SEQ ID NO:
- 273 is a protein having UbiA-like prenyltransferase activity;
- (II) a heterologous polynucleotide having a nucleotide sequence selected from the group consisting of the nucleotide sequences in (1) to (4) below:
- (1) a nucleotide sequence comprising positions 21793 to 22877 of the nucleotide sequence set forth in SEQ ID NO:
- 266, (2) a nucleotide sequence which hybridizes with every nucleotide in the full length complementary sequence in (1) under stringent conditions wherein said stringent conditions comprise washing with 2× saline-sodium citrate (SSC) buffer and 0.5% sodium dodecyl sulfate (SDS) at 60° C. for 20 minutes, and then washing with 0.2×SSC and 0.1% SDS at 60° C. for 15 minutes;
- (3) the nucleotide sequence in (1) in which one to ten nucleotides are deleted, substituted, inserted, or added, and;
- (4) a nucleotide sequence with at least 90% sequence identity to the nucleotide sequence in (1)
- wherein positions of the nucleotide sequence corresponding to positions 21793 to 22877 in SEQ ID NO:
- 266 encode a protein having UbiA-like prenyltransferase activity.
11 more elements
A recombinant vector comprising one or more polynucleotides and a promoter that is heterologous to the one or more polynucleotides, wherein the one or more polynucleotides are selected from the following (a), (b), (c), (d), (e), (f), (g) and (h):
- (a) a polynucleotide comprising the nucleotide sequence of SEQ ID NO:
- 266,
- (b) a polynucleotide encoding a polypeptide which consists of an amino acid sequence selected from the group consisting of the amino acid sequence of SEQ ID NOs:
- 269, 270, 273, 274, and 275,
- wherein SEQ ID NO:
- 269 is a protein having Cytochrome P450 monooxygenase-1 activity, SEQ ID NO:
- 270 is a protein having Cytochrome P450 monooxygenase-2 activity, SEQ ID NO:
- 273 is a protein having UbiA-like prenyltransferase activity, SEQ ID NO:
- 274 is a protein having Acetyltransferase activity, and SEQ ID NO:
- 275 is a protein having Acetyltransferase-2 activity;
- (c) a polynucleotide with at least 90% sequence identity to a polynucleotide encoding the amino acid sequence of SEQ ID NO:
- 269 and having Cytochrome P450 monooxygenase-1 activity,
- (d) a polynucleotide with at least 90% sequence identity to a polynucleotide encoding the amino acid sequence of SEQ ID NO:
- 270 and having Cytochrome P450 monooxygenase-2 activity,
- (e) a polynucleotide with at least 90% sequence identity to a polynucleotide encoding the amino acid sequence of SEQ ID NO:
- 273 and having UbiA-like prenyltransferase activity,
- (f) a polynucleotide with at least 90% sequence identity to a polynucleotide encoding the amino acid sequence of SEQ ID NO:
- 274 and having Acetyltransferase activity,
- (g) a polynucleotide with at least 90% sequence identity to a polynucleotide encoding the amino acid sequence of SEQ ID NO:
- 275 and having Acetyltransferase-2 activity,
- (h) a polynucleotide comprising a nucleotide sequence selected from the group consisting of the nucleotide sequences in (i), (ii), (iii), (iv), and (v):
- (i) a nucleotide sequence comprising positions 13266 to 15144 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (ii) a nucleotide sequence comprising positions 16220 to 18018 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (iii) a nucleotide sequence comprising positions 21793 to 22877 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- (iv) a nucleotide sequence comprising positions 23205 to 24773 of the nucleotide sequence set forth in SEQ ID NO:
- 266, and
- (v) a nucleotide sequence comprising positions 25824 to 27178 of the nucleotide sequence set forth in SEQ ID NO:
- 266,
- wherein positions of the nucleotide sequence corresponding to positions 13266 to 15144 in SEQ ID NO:
- 266 encode a protein having Cytochrome P450 monooxygenase-1 activity, positions of the nucleotide sequence corresponding to positions 16220 to 18018 in SEQ ID NO:
- 266 encode a protein having Cytochrome P450 monooxygenase-2 activity, positions of the nucleotide sequence corresponding to positions 21793 to 22877 in SEQ ID NO:
- 266 encode a protein having UbiA-like prenyltransferase activity, positions of the nucleotide sequence corresponding to positions 23205 to 24773 in SEQ ID NO:
- 266 encode a protein having Acetyltransferase activity, and positions of the nucleotide sequence corresponding to positions 25824 to 27178 in SEQ ID NO:
- 266 encode a protein having Acetyltransferase-2 activity.
34 more elements
Dependencies are inferred from the claim text.